EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing Pharmacoequity in Low‐ and Middle‐Income Countries via Model Informed Drug Development

Henry Enzama iD, Francis Williams Ojara iD, Ian S Haworth iD, Sandra Cvijic iD, Catriona Waitt iD, Thaddeus H Grasela iD

Clinical and Translational Science · 2026-05 · 19 (5)

DOI: 10.1111/cts.70571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 27.04.2026. Verfasst von Henry Enzama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Developing Countries, Drug Development, Economics, Pharmaceutical. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Across low‐ and middle‐income countries (LMICs) inequities in access to safe, effective medicines persist due to limited regulatory capacity, inadequate financing, and insufficient local data. Regulatory authorities are engaging with model‐informed drug development (MIDD), but uneven technical readiness and resource gaps limit uptake. Physiologically based and population pharmacokinetic modeling can strengthen regulatory review and optimize dosing. When aligned with global harmonization initiatives, these tools can support evidence‐based decisions and advance pharmacoequity by ensuring context‐appropriate therapies reach patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developing CountriesDrug DevelopmentEconomics, PharmaceuticalHumans

Autor:innen und Institutionen

  • Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Pharmacology and Therapeutics, Gulu University, Gulu, Uganda.
  • Department of Pharmacology and Pharmaceutical Sciences, USC Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, USA.
  • Department of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, Belgrade, Serbia.
  • Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
  • Azimuth Global Health Consulting, Buffalo, New York, USA.

ORCID-Profile: Henry Enzama, Francis Williams Ojara, Ian S Haworth, Sandra Cvijic, Catriona Waitt, Thaddeus H Grasela

Zitieren

APA

Enzama, H., Ojara, F. W., Haworth, I. S., Cvijic, S., Waitt, C., & Grasela, T. H. (2026). Advancing Pharmacoequity in Low‐ and Middle‐Income Countries via Model Informed Drug Development. Clinical and Translational Science, 19(5). https://doi.org/10.1111/cts.70571

Vancouver

Enzama H, Ojara FW, Haworth IS, Cvijic S, Waitt C, Grasela TH. Advancing Pharmacoequity in Low‐ and Middle‐Income Countries via Model Informed Drug Development. Clinical and Translational Science. 2026;19(5). doi:10.1111/cts.70571

BibTeX
@article{Enzama2026,
  author = {Enzama, Henry and Ojara, Francis Williams and Haworth, Ian S and Cvijic, Sandra and Waitt, Catriona and Grasela, Thaddeus H},
  title = {Advancing Pharmacoequity in Low‐ and Middle‐Income Countries via Model Informed Drug Development},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {5},
  doi = {10.1111/cts.70571}
}
Kostenlos starten →